Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation - PubMed (original) (raw)
. 2001 Dec 14;276(50):47107-15.
doi: 10.1074/jbc.M104516200. Epub 2001 Oct 15.
Affiliations
- PMID: 11602574
- DOI: 10.1074/jbc.M104516200
Free article
Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation
A Troyano et al. J Biol Chem. 2001.
Free article
Abstract
Treatment with the DNA topoisomerase inhibitors etoposide, doxorubicin, and camptothecin, and with the alkylating agents cisplatin and melphalan, caused peroxide accumulation and apoptosis in U-937 human promonocytic cells. Preincubation with the reduced glutathione (GSH) synthesis inhibitor l-buthionine-(S,R)-sulfoximine (BSO) always potentiated peroxide accumulation. However, although GSH depletion potentiated the toxicity of cisplatin and melphalan, occasionally switching the mode of death from apoptosis to necrosis, it did not affect the toxicity of the other antitumor drugs. Hypoxia or preincubation with antioxidant agents attenuated death induction, apoptotic and necrotic, by alkylating drugs. The generation of necrosis by cisplatin could not be mimicked by addition of exogenous H(2)O(2) instead of BSO and was not adequately explained by caspase inactivation nor by a selective fall in ATP content. Treatment with cisplatin and melphalan caused a late decrease in mitochondrial transmembrane potential (DeltaPsim), which was much greater during necrosis than during apoptosis. The administration of the antioxidant agents N-acetyl-l-cysteine and butylated hydroxyanisole after pulse treatment with cisplatin or melphalan did not affect apoptosis but attenuated necrosis. Under these conditions, both antioxidants attenuated the necrosis-associated DeltaPsim decrease. These results indicate that oxidation-mediated alterations in mitochondrial function regulate the selection between apoptosis and necrosis in alkylating drug-treated human promonocytic cells.
Similar articles
- Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress.
Sancho P, Fernández C, Yuste VJ, Amrán D, Ramos AM, de Blas E, Susin SA, Aller P. Sancho P, et al. Apoptosis. 2006 May;11(5):673-86. doi: 10.1007/s10495-006-5879-3. Apoptosis. 2006. PMID: 16532269 - Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents.
Biroccio A, Benassi B, Fiorentino F, Zupi G. Biroccio A, et al. Neoplasia. 2004 May-Jun;6(3):195-206. doi: 10.1593/neo.3370. Neoplasia. 2004. PMID: 15153331 Free PMC article. - The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells.
Troyano A, Sancho P, Fernández C, de Blas E, Bernardi P, Aller P. Troyano A, et al. Cell Death Differ. 2003 Aug;10(8):889-98. doi: 10.1038/sj.cdd.4401249. Cell Death Differ. 2003. PMID: 12867996 - Cisplatin chemotherapy and renal function.
Zhang J, Ye ZW, Tew KD, Townsend DM. Zhang J, et al. Adv Cancer Res. 2021;152:305-327. doi: 10.1016/bs.acr.2021.03.008. Epub 2021 Apr 28. Adv Cancer Res. 2021. PMID: 34353441 Free PMC article. Review.
Cited by
- The effects of cadmium exposure on the oxidative state and cell death in the gill of freshwater crab Sinopotamon henanense.
Wang J, Zhang P, Shen Q, Wang Q, Liu D, Li J, Wang L. Wang J, et al. PLoS One. 2013 May 30;8(5):e64020. doi: 10.1371/journal.pone.0064020. Print 2013. PLoS One. 2013. PMID: 23737962 Free PMC article. - Design, Synthesis and Antiproliferative Evaluation of Bis-Indole Derivatives with a Phenyl Linker: Focus on Autophagy.
Marianna B, Radka M, Martin K, Janka V, Jan M. Marianna B, et al. Molecules. 2022 Dec 28;28(1):251. doi: 10.3390/molecules28010251. Molecules. 2022. PMID: 36615444 Free PMC article. - Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
Chen HH, Kuo MT. Chen HH, et al. Met Based Drugs. 2010;2010:430939. doi: 10.1155/2010/430939. Epub 2010 Sep 14. Met Based Drugs. 2010. PMID: 20885916 Free PMC article. - L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.
Lin J, Raoof DA, Thomas DG, Greenson JK, Giordano TJ, Robinson GS, Bourner MJ, Bauer CT, Orringer MB, Beer DG. Lin J, et al. Neoplasia. 2004 Jan-Feb;6(1):74-84. doi: 10.1016/s1476-5586(04)80054-x. Neoplasia. 2004. PMID: 15068672 Free PMC article. - The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy.
Milacic V, Dou QP. Milacic V, et al. Coord Chem Rev. 2009;253(11-12):1649-1660. doi: 10.1016/j.ccr.2009.01.032. Coord Chem Rev. 2009. PMID: 20047011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources